Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
21.97
-0.03 (-0.14%)
Jun 29, 2026, 10:15 AM EDT - Market open
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change (1Y)
25
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,729,036
Market Cap
1.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Novavax | 749 |
| Immatics | 678 |
| MannKind | 592 |
| Ardelyx | 489 |
| EyePoint | 214 |
| MoonLake Immunotherapeutics | 130 |
| Inhibrx Biosciences | 110 |
JBIO News
- 3 days ago - Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors - GlobeNewsWire
- 14 days ago - Jade Biosciences initiated with a Buy at UBS - TheFly
- 23 days ago - Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 24 days ago - Jade Biosciences Proxy statement: Proxy filing - Filings
- 25 days ago - Jade Biosciences 10M share Secondary priced at $15.00 - TheFly
- 25 days ago - Jade Biosciences Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 25 days ago - Jade Biosciences announces common stock offering, no amount given - TheFly
- 25 days ago - Jade Biosciences Announces Proposed Underwritten Public Offering - GlobeNewsWire